Effect of benzo(a)pyrene exposure on fluoranthene metabolism by mouse adipose tissue microsomes

References

• Babson JR, Russo-Rodriguez S, Rastetter WH, Wogan GN. 1986. In vitro DNA-binding of microsomally-activated fluoranthene: evidence that the major product is a fluoranthene N2–deoxyguanosine adduct. Carcinogenesis 7:859–865.
   PubMed Web of Science ®Google Scholar
• Beach JB, Pellizzari E, Keever JT, Ellis L. 2000. Determination of benzo(a)pyrene and other polycyclic aromatic hydrocarbons (PAHs) at trace levels in human tissues. J Anal Toxicol 24:670–677.
   PubMed Web of Science ®Google Scholar
• Bradford M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein, utilizing the principle of dye binding. Anal Biochem 72:248–254.
   PubMed Web of Science ®Google Scholar
• Cassee FR, Groten JP, van Bladeren PJ, Feron VJ. 1998. Toxicological evaluation and risk assessment of chemical mixtures. Crit Rev Toxicol 28:73–101.
   PubMed Web of Science ®Google Scholar
• Chen JK, Wu ZL, Liu YG, Lei YX. 2000. Effects of metabolites of benzo(a)pyrene on unscheduled DNA synthesis in BALB/3T3 cell line. Chemosphere 41:139–142.
   PubMed Web of Science ®Google Scholar
• Ekins S, Ring BJ, Grace J, McRobie-Belle DJ, Wrighton SA. 2000. Present and future invitro approaches for drug metabolism. J Pharmacol Toxicol Meth 44:313–324.
   PubMed Web of Science ®Google Scholar
• EPA. 2001. Integrated risk information system (IRIS). National Center for Environmental Assessment. Available online at: http://www.epa.gov/iris/index.html, accessed May 2003.
   Google Scholar
• Falahatpisheh MH, Kerzee JK, Metz RP, Donnelly KC, Ramos KS. 2004. Inducible cytochrome P450 activities in renal glomerular mesangial cells: biochemical basis for antagonistic interactions among nephrocarcinogenic polycyclic aromatic hydrocarbons. J Carcinogen 3:12.
   PubMedGoogle Scholar
• Galván N, Teske DE, Zhou G, Moorthy B, MacWilliams PS, Czuprynski CJ, Jefcoate CR. 2005. Induction of CYP1A1 and CYP1B1 in liver and lung by benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene do not affect distribution of polycyclic hydrocarbons to target tissue: role of AhR and CYP1B1 in bone marrow cytotoxicity. Toxicol Appl Pharmacol 202:244–257.
   PubMed Web of Science ®Google Scholar
• Goldman R, Enewold L, Pellizzari E, Beach JB, Bowman ED, Krishnan SS, Shields PG. 2001. Smoking increases carcinogenic polycyclic aromatic hydrocarbons in human lung tissue. Cancer Res 61:6367–6371.
   PubMed Web of Science ®Google Scholar
• Haas BS, Brooks EE, Schumann KE, Dornfeld SS. 1981. Synergistic, additive, and antagonistic mutagenic responses to binary mixtures of benzo(a)pyrene and benzo(e)pyrene as detected by strains TA98 and TA100 in the Salmonella/microsome assay. Environ Mutagen 3:159–166.
   PubMedGoogle Scholar
• Harris DL, Washington MK, Hood DB, Roberts II LJ, Ramesh A. 2009a. Dietary fat-influenced development of colon neoplasia in ApcMin mice exposed to benzo(a)pyrene. Toxicol Pathol 37:938–946.
   PubMed Web of Science ®Google Scholar
• Harris DL, Huderson AC, Niaz MS, Ford JJ, Archibong AE, Ramesh A. 2009b. Comparative metabolism of benzo(a)pyrene by ovarian microsomes of various species. Environ Toxicol 24:603–609.
   PubMed Web of Science ®Google Scholar
• Hughes NC, Phillips DH. 1990. Covalent binding of dibenzpyrenes and benzo[a]pyrene to DNA: evidence for synergistic and inhibitory interactions when applied in combination to mouse skin. Carcinogenesis 11:1611–1619.
   PubMed Web of Science ®Google Scholar
• Hutchins DA, Skipper PL, Naylor S, Tannenbaum SR. 1988. Isolation and characterization of the major fluoranthene-hemoglobin adducts formed in vivo in the rat. Cancer Res 48:4756–4761.
   PubMed Web of Science ®Google Scholar
• ILAR. 1996. Guide for the care and use of laboratory animals. Washongton, DC: The National Academies Press. 140 pp.
   Google Scholar
• IPCS. 1998. Environmental health criteria 202: Selected non-heterocyclic polycyclic aromatic hydrocarbons. Lyon, France: International Programme on Chemical Safety, World Health Organization.
   Google Scholar
• Kistos CP, Edler L. 2005. Cancer risk assessment for mixtures. In: Edler L, Kistos CP, editors. Recent advances in quantitative methods in cancer and human health risk assessment. Chichester, West Sussex, UK: John Wiley & Sons Ltd. pp 283–298.
   Google Scholar
• Knuckles ME, Inyang F, Ramesh A. 2001. Acute and subchronic oral toxicity of benzo(a)pyrene in F-344 rats. Tox Sci 61:382–388.
   PubMed Web of Science ®Google Scholar
• Knuckles ME, Inyang F, Ramesh A. 2004. Acute and subchronic oral toxicity of fluoranthene in F-344 rats. Ecotoxicol Environ Saf 59:102–108.
   PubMed Web of Science ®Google Scholar
• Krishnamurthi K, Devi SS, Chakrabarti T. 2007. The genotoxicity of priority polycyclic aromatic hydrocarbons (PAHs) containing sludge samples. Toxicol Mech Method 17:1–12.
   PubMed Web of Science ®Google Scholar
• Luch A (Ed.). 2006. The carcinogenic effects of polycyclic aromatic hydrocarbons. London: Imperial College Press. 489 pp.
   Google Scholar
• Moir D, Viau A, Chu I, Withey J, McMullen E. 1998. Pharmacokinetics of benzoz(a)pyrene in the rat. J Toxicol Environ Health A 53:507–530.
   PubMed Web of Science ®Google Scholar
• NIH. 1981. Guidelines for the laboratory use of chemical carcinogens. NIH Publication No. 81–2385. Washington, DC: National Institutes of Health, US Government Printing Office.
   Google Scholar
• Phillips DH, Grover PL. 1994. Polycyclic hydrocarbon activation: bay regions and beyond. Drug Metab Rev 26:443–467.
   PubMed Web of Science ®Google Scholar
• Piskorska-Pliszczynska J, Keys B, Safe S, Newman MS. 1986. The cytosolic receptor binding affinities and AHH induction potencies of 29 polynuclear aromatic hydrocarbons. Toxicol Lett 34:67–74.
   PubMed Web of Science ®Google Scholar
• Ramesh A, Inyang F, Hood DB, Archibong AE, Knuckles ME, Nyanda AM. 2001. Metabolism, bioavailability, and toxicokinetics of benzo(a)pyrene in F344 rats following oral administration. Exp Toxic Pathol 53:275–290.
   PubMed Web of Science ®Google Scholar
• Ramesh A, Inyang F, Hood DB, Knuckles ME. 2000. Aryl hydrocarbon hydroxylase activity in F-344 rats subchronically exposed to benzo(a)pyrene and fluoranthene through diet. J Biochem Mol Toxicol 14:155–161.
   PubMed Web of Science ®Google Scholar
• Ramesh A, Walker SA, Hood DB, Guillen MD, Schneider H, Weyand EH. 2004. Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons (review). Int J Toxicol 23:301–333.
   PubMed Web of Science ®Google Scholar
• Sattar A, Hewer A, Phillips DH, Campbell FC. 1999. Metabolic proficiency and benzo(a)pyrene DNA adduct formation in ApcMin mouse adenomas and uninvolved mucosa. Carcinogenesis 20:1097–1101.
   PubMed Web of Science ®Google Scholar
• Schenkman JB, Jansson I. 1999. Measurement of cytochrome P450. In: Maines MD, Costa LG, Hodgson E, Reed DJ, Sipes IG, editors. Current protocols in toxicology. Hoboken, NJ: John Wiley. pp 4.1.1–4.1.14.
   Google Scholar
• Silkworth JB, Lipinskas T, Stoner CR. 1995. Immunosuppressive potential of several polycyclic aromatic hydrocarbons (PAHs) found at a superfund site: new model used to evaluate additive interactions between benzo[a]pyrene and TCDD. Toxicology 105:375–386.
   PubMed Web of Science ®Google Scholar
• Sjögren M, Ehrenberg I, Rannug U. 1996. Relevance of different biological assays in assessing initiating and promoting properties of polycyclic aromatic hydrocarbons with respect to carcinogenic potency. Mutat Res 358:97–112.
   PubMed Web of Science ®Google Scholar
• Smith TL, Merry ST, Harris DL, Joe Ford J, Ike J, Archibong AE, Ramesh A. 2007. Species-specific testicular and hepatic microsomal metabolism of benzo(a)pyrene, an ubiquitous toxicant and endocrine disruptor. Toxicol In Vitro 4:753–758.
   Google Scholar
• Staal YCM, Hebels DGAJ, van Herwijnen MHM, Gottschalk RWH, van Schooten FJ, van Delft JHM. 2007. Binary PAH mixtures cause additive or antagonistic effects on gene expression but synergistic effects on DNA adduct formation. Carcinogenesis 28:2632–2640.
   PubMed Web of Science ®Google Scholar
• Vaca C, Tornquist M, Rannug U, Lindahl-Kiessling K, Ahnstrom G, Ehrenberg L. 1992. On the bioactivation and genotoxic action of fluoranthene. Arch Toxicol 66:538–545.
   PubMed Web of Science ®Google Scholar
• vanDuuren BL, Goldschmidt BM. 1976. Cocarcinogenic and tumor-promoting agents in tobacco carcinogenesis. J Natl Cancer Inst 56:1237–1242.
   PubMedGoogle Scholar
• Walker SA, Addai AB, Mathis M, Ramesh A. 2007. Effect of dietary fat on metabolism and DNA adduct formation after acute oral exposure of F-344 rats to fluoranthene. J Nutr Biochem 18:236–249.
   PubMed Web of Science ®Google Scholar
• Walker SA, Whitten LB, Seals GB, Lee WE, Archibong AE, Ramesh A. 2006. Inter-species comparison of liver and small intestinal microsomal metabolism of fluoranthene. Food Chem Toxicol 44:380–387.
   PubMed Web of Science ®Google Scholar
• Warshawsky D, Barkley W, Bingham E. 1993. Factors affecting carcinogenic potential of mixtures. Fundam Appl Toxicol 20:376–382.
   PubMedGoogle Scholar
• Willett KL, Gardinali PR, Sericano JL, Wade TL, Safe SH. 1997. Characterization of the rat hepatoma cell bioassay for evaluation of environmental samples containing polynuclear aromatic hydrocarbons (PAHs). Arch Environ Contam Toxicol 32:442–448.
   PubMed Web of Science ®Google Scholar